Metoprolol immediate release pharmacokinetics
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol Immediate Release Pharmacokinetics: Key Parameters
Absorption, Peak Plasma Concentration, and Area Under Curve (AUC)
Immediate-release (IR) metoprolol is rapidly absorbed after oral administration, leading to a quick rise in plasma concentration. The maximum plasma concentration (C_max) and the area under the concentration–time curve (AUC) increase in a dose-dependent manner, meaning higher doses result in higher C_max and AUC values. The time to reach maximum concentration (T_max) is also dose-dependent, but typically occurs within a few hours after dosing .
Influence of CYP2D6 Genotype on Metoprolol IR Pharmacokinetics
Metoprolol is mainly metabolized by the CYP2D6 enzyme, which shows significant genetic variability among individuals. This genetic variability leads to large differences in metoprolol pharmacokinetics. Poor metabolizers (PMs) have much higher peak plasma concentrations, AUC, and longer elimination half-life compared to extensive (EMs) and ultrarapid metabolizers (UMs). For example, PMs can have up to 4.9 times higher AUC and 2.3 times longer half-life than EMs, and up to 13 times higher AUC than UMs. Additionally, the metabolism of the R- and S-enantiomers of metoprolol is also genotype-dependent, with UMs and EMs metabolizing the R-enantiomer about 40% faster than the S-enantiomer .
Comparison with Extended-Release Formulations
When comparing IR metoprolol to extended-release (ER or CR/XL) formulations, studies show that a 50 mg IR dose three times daily produces similar peak plasma levels to a 200 mg CR/XL dose once daily. However, the IR formulation results in higher peak and more variable plasma concentrations, while the ER formulation provides more stable levels over 24 hours. The total exposure (AUC) is similar between the two, but the IR formulation leads to greater fluctuations in plasma concentration Andersson2001Karlson2013.
Impact of Drug Interactions
Co-administration of CYP2D6 inhibitors, such as paroxetine, significantly increases the AUC and C_max of both S- and R-metoprolol, with a more pronounced effect on the R-enantiomer. This interaction is similar for both IR and ER formulations, leading to a loss of stereoselective metabolism and potentially greater beta-blockade .
Effects of Gastric Bypass Surgery
Roux-en-Y gastric bypass (RYGB) surgery can alter the pharmacokinetics of orally administered metoprolol. For IR metoprolol, there is considerable variability in how much the AUC changes after surgery, with some patients experiencing increased and others decreased exposure. This variability highlights the need for close monitoring and possible dose adjustments in patients who have undergone RYGB Gesquiere2015Yska2019.
Enantiomer-Specific Pharmacokinetics
Studies have shown that the S-enantiomer of metoprolol generally has higher C_max, T_max, and AUC compared to the R-enantiomer. Gender differences have also been observed, with women showing higher C_max and AUC values than men .
Conclusion
The pharmacokinetics of immediate-release metoprolol are characterized by rapid absorption, dose-dependent increases in C_max and AUC, and significant variability due to CYP2D6 genotype. Drug interactions and physiological changes, such as those following gastric bypass surgery, can further influence metoprolol exposure. Understanding these factors is essential for optimizing dosing and minimizing adverse effects in patients receiving metoprolol IR.
Sources and full results
Most relevant research papers on this topic